SEALSQ Corp (NASDAQ: LAES) announced that production samples for its first‑generation QS7001 Secure Element and QVault TPM hardware families are now available. The four products—QS7001 V1, QS7001 V2, QVault TPM 183, and QVault TPM 185—represent the company’s first post‑quantum security offerings and mark a critical step toward commercial launch.
All four products are tracking green across the Common Criteria, FIPS 140‑3, and Trusted Computing Group certification programs through the fourth quarter of 2026. The certification roadmap positions SEALSQ to meet the reporting obligations of the EU Cyber Resilience Act, which begin on September 11 2026, and the main obligations that start on December 11 2027, as well as the U.S. Cyber Trust Mark program that is expected to launch in 2025.
Financially, SEALSQ has shown strong revenue growth, reporting a 66% increase to $18 million in preliminary FY 2025 results. The company maintains a robust cash reserve exceeding $425 million and has a $170 million pipeline for 2026‑2028, offsetting recent losses. These metrics suggest the firm has the resources to bring the new products to market and sustain its R&D investments.
The availability of production samples and the certification progress align with the growing demand for post‑quantum cryptography, driven by upcoming regulatory mandates and the NSA CNSA 2.0 deadline in January 2027. By securing early compliance, SEALSQ positions itself ahead of competitors in the secure‑hardware market, potentially capturing a share of the expanding post‑quantum security segment.
With production samples in hand and a clear certification path, SEALSQ is poised to transition from development to commercial deployment, targeting early market entry in the second half of 2026 as regulatory deadlines approach.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.